ProfileGDS4718 / 235617_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 5% 10% 4% 10% 7% 23% 10% 8% 8% 9% 7% 10% 5% 10% 19% 7% 8% 5% 12% 8% 7% 7% 5% 4% 8% 11% 7% 13% 16% 8% 5% 2% 9% 5% 4% 3% 9% 7% 7% 4% 7% 15% 4% 2% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.604145
GSM549102patient 115, normal, homogenized [OPG study]3.7884810
GSM549104patient 119, normal, homogenized [OPG study]3.515574
GSM549108patient 138, normal, homogenized [OPG study]3.793110
GSM549119patient 077, normal, homogenized [OPG study]3.653817
GSM549133patient 032, cancer, homogenized [OPG study]4.2086623
GSM549139patient 042, cancer, homogenized [OPG study]3.7678610
GSM549099patient 107, normal, homogenized [OPG study]3.708138
GSM549109patient 139, normal, homogenized [OPG study]3.713268
GSM549110patient 046, normal, homogenized [OPG study]3.74569
GSM549114patient 063, normal, homogenized [OPG study]3.658737
GSM549122patient 082, normal, homogenized [OPG study]3.7837610
GSM549134patient 033, cancer, homogenized [OPG study]3.570365
GSM549136patient 036, cancer, homogenized [OPG study]3.7235110
GSM549140patient 044, cancer, homogenized [OPG study]4.0824819
GSM549111patient 047, normal, homogenized [OPG study]3.665617
GSM549113patient 057, normal, homogenized [OPG study]3.670648
GSM549132patient 031, cancer, homogenized [OPG study]3.560155
GSM549137patient 038, cancer, homogenized [OPG study]3.8351512
GSM549142patient 047, cancer, homogenized [OPG study]3.76928
GSM549100patient 110, normal, homogenized [OPG study]3.650497
GSM549107patient 135, normal, homogenized [OPG study]3.636167
GSM549115patient 068, normal, homogenized [OPG study]3.581455
GSM549116patient 072, normal, homogenized [OPG study]3.559154
GSM549120patient 078, normal, homogenized [OPG study]3.682468
GSM549131patient 030, cancer, homogenized [OPG study]3.788411
GSM549118patient 074, normal, homogenized [OPG study]3.678627
GSM549129patient 027, cancer, homogenized [OPG study]3.9060413
GSM549123patient 088, normal, homogenized [OPG study]4.0143116
GSM549124patient 006, cancer, homogenized [OPG study]3.715668
GSM549126patient 015, cancer, homogenized [OPG study]3.584195
GSM549128patient 025, cancer, homogenized [OPG study]3.398922
GSM549103patient 117, normal, homogenized [OPG study]3.753219
GSM549117patient 073, normal, homogenized [OPG study]3.582455
GSM549138patient 041, cancer, homogenized [OPG study]3.542044
GSM549141patient 045, cancer, homogenized [OPG study]3.443993
GSM549130patient 028, cancer, homogenized [OPG study]3.737559
GSM549101patient 111, normal, homogenized [OPG study]3.658617
GSM549105patient 128, normal, homogenized [OPG study]3.663977
GSM549106patient 134, normal, homogenized [OPG study]3.491654
GSM549112patient 048, normal, homogenized [OPG study]3.679857
GSM549125patient 011, cancer, homogenized [OPG study]3.9750715
GSM549127patient 024, cancer, homogenized [OPG study]3.498494
GSM549135patient 035, cancer, homogenized [OPG study]3.360752